77 related articles for article (PubMed ID: 9022395)
1. [Nuclear medicine. Technetium-99m-Tetrofosmin--a reliable perfusion marker for myocardial scintigraphy].
Nuklearmedizin; 1996; (3 Suppl):1-4. PubMed ID: 9022395
[No Abstract] [Full Text] [Related]
2. Increased tc-99m tetrofosmin uptake in a mediastinal tumor during myocardial perfusion imaging.
Vijayakumar V; Soloff E; Rahman AM
Clin Nucl Med; 2004 Jun; 29(6):390-1. PubMed ID: 15166893
[No Abstract] [Full Text] [Related]
3. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
5. Technetium tetrofosmin myocardial perfusion imaging in women.
Akinboboye O; Nichols K
J Nucl Cardiol; 2006 Sep; 13(5):603-4. PubMed ID: 16945737
[No Abstract] [Full Text] [Related]
6. Intense uptake of technetium-99m tetrofosmin by lactating breasts.
Yamamoto W; Shuke N; Usui K; Aburano T; Takehara N; Kikuchi K
Clin Nucl Med; 2001 Jan; 26(1):76-7. PubMed ID: 11139067
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
[TBL] [Abstract][Full Text] [Related]
8. Incidental diagnosis of breast carcinoma following technetium 99m tetrofosmin (myoview) scintigraphy for evaluation of ischaemic heart disease.
Torreggiani W; Brenner C; Hogan B
Ir Med J; 1999; 92(7):437-8. PubMed ID: 10967869
[No Abstract] [Full Text] [Related]
9. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
10. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
12. Stress technetium-99m tetrofosmin myocardial scintigraphy: a new one-hour protocol for the detection of coronary artery disease.
Matsuda J; Miyamoto N; Ikushima I; Takenaga M; Koiwaya Y; Eto T
J Cardiol; 1998 Oct; 32(4):219-26. PubMed ID: 9833228
[TBL] [Abstract][Full Text] [Related]
13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
15. Tetrofosmin scintigraphy of thyroid disease.
Kresnik E; Gallowitsch HJ; Mikosch P; Molnar M; Lind P
Eur J Nucl Med; 1997 Oct; 24(10):1332. PubMed ID: 9432470
[No Abstract] [Full Text] [Related]
16. Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer.
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
J Nucl Med; 1998 Oct; 39(10):1830-1. PubMed ID: 9776299
[No Abstract] [Full Text] [Related]
17. Technetium-99m-tetrofosmin: a new agent for melanoma imaging?
Meghdadi S; Karanikas G; Schlagbauer-Wadl H; Jansen B; Chehne F; Rodrigues M; Pehamberger H; Sinzinger H
Anticancer Res; 1998; 18(4A):2759-62. PubMed ID: 9703942
[TBL] [Abstract][Full Text] [Related]
18. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
Söderlund V; Jonsson C; Bauer HC; Brosjö O; Jacobsson H
J Nucl Med; 1997 May; 38(5):682-6. PubMed ID: 9170427
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-tetrofosmin myocardial imaging in cardiotoxicity screening for left-sided breast cancer irradiation.
Pistevou-Gompaki K; Eleftheriadis D; Trontzos C; Goutzioulis M; Kouloulias V; Eleftheriadis N; Sofroniadis I
Acta Oncol; 2003; 42(4):349-51. PubMed ID: 12899510
[No Abstract] [Full Text] [Related]
20. [Technetium 99m tetrofosmin as a myocardial perfusion marker in diagnosis of coronary heart disease. Validation a one day rest-stress protocol].
Bair HJ; Altstidl R; Feistel H
Rontgenpraxis; 1997 Sep; 50(9):259-64. PubMed ID: 9411806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
